Zealand's royalty deal; Khartis raises money for TED drug

Khartis raises $50M Series B; Zealand sells rusfertide royalties to Royalty Pharma for $100M; MapLight gets $150M placement despite 71% stock drop.

Raccontata daendpoints.news